GSTN now allows Promoters/Directors of new GST Applicant companies to complete Biometric Authentication at a GSK in their ...
The existing system required for applicants selected for Biometric Authentication to visit the designated GSK mapped to their ...
GSK plc (GSK) has announced on Monday that the FDA has accepted its Biologics License Application (BLA) for depemokimab for regulatory review in two indications.The proposed ...
HHS Assistant Secretary of Public Affairs Tom Corry unexpectedly stepped down on Feb. 28. In a brief post on X Monday morning ...
In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, ...
The US Food and Drug Administration (FDA) has accepted for review GSK’s Biologics License Application for depemokimab.
Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...
FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
Now biometric authentication in your home state is possible when you do GST registration in another state, GSTN Advisory on ...
New data shows Australia's gender pay gap has narrowed, but working women are still more than $28,000 a year worse off than ...
The NCSD Speakers Bureau Roster features nearly 250 public speakers, celebrities, cancer survivors, and medical professionals eligible to ...